United Kingdom

People: Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

23 Aug 2019
Change (% chg)

$-1.59 (-5.31%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sullivan, Timothy 

Mr. Timothy Sullivan is Chief Financial Officer, Treasurer of the Company. From January 2014 to October 2017, Mr. Sullivan served as Partner at AJU IB Investment, a venture capital firm, at which he led the firm’s investments in life sciences companies. Prior to joining AJU IB Investment, from December 2011 to January 2014, Mr. Sullivan was Managing Director, Head of Life Sciences at RBS Citizens. Mr. Sullivan was an observer on our board of directors from November 2014 until October 2017. Mr. Sullivan has previously served as a director of G1 Therapeutics, Inc. and Molecular Templates, Inc. Mr. Sullivan received his M.B.A. from the Columbia Business School and his B.A. in Biology from Harvard University.

Basic Compensation

Total Annual Compensation, USD 570,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 289,752
Fiscal Year Total, USD 859,752

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --